Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85,174Revenue $M6,932Net Margin (%)27.8Z-Score18.2
Enterprise Value $M83,903EPS $7.8Operating Margin %38.4F-Score8
P/E(ttm))34.1Cash Flow Per Share $7.4Pre-tax Margin (%)38.2Higher ROA y-yY
Price/Book8.210-y EBITDA Growth Rate %25.7Quick Ratio1.9Cash flow > EarningsY
Price/Sales9.55-y EBITDA Growth Rate %20.1Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %51.4ROA % (ttm)20.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)27.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M236ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 360.679%New holding, 80000 sh.80,000
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 360.679%New holding, 31391 sh.31,391
BIIBRay Dalio 2014-09-30 Buy $299.29 - $346.3
($329.79)
$ 360.679%New holding, 1646 sh.1,646
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 360.679%Reduce -58.26%233,600
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 360.6720%Add 386.61%88,885
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 360.6720%Add 41.76%8,632
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 360.6720%Sold Out0
BIIBAndreas Halvorsen 2014-06-30 Sold Out -0.5%$274 - $320.13
($300.74)
$ 360.6720%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 360.6720%Sold Out0
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 360.6720%Sold Out0
BIIBJohn Burbank 2014-06-30 Sold Out -0.01%$274 - $320.13
($300.74)
$ 360.6720%Sold Out0
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 360.6714%New holding, 116000 sh.116,000
BIIBAndreas Halvorsen 2014-03-31 Buy 0.5%$273.518 - $351.94
($316.4)
$ 360.6714%New holding, 388900 sh.388,900
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 360.6714%New holding, 3931 sh.3,931
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 360.6714%New holding, 7500 sh.7,500
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 360.6714%New holding, 6089 sh.6,089
BIIBJohn Burbank 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 360.6714%New holding, 783 sh.783
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 360.6714%Add 796.27%18,266
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 360.6714%Reduce -32.19%599,400
BIIBRay Dalio 2014-03-31 Sold Out -0.04%$273.518 - $351.94
($316.4)
$ 360.6714%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ken Heebner 2014-09-3080,0000.030.75New Buy
BIIB Joel Greenblatt 2014-09-3031,3910.010.1New Buy
BIIB Ray Dalio 2014-09-301,64600New Buy
BIIB Mario Gabelli 2014-09-304,63500.01+11.02%
BIIB Frank Sands 2014-09-304,952,0962.14.1+1.24%
BIIB Ron Baron 2014-09-308,61300.01-0.22%
BIIB PRIMECAP Management 2014-09-3017,216,6317.296.1-0.24%
BIIB Ken Fisher 2014-09-3078,4570.030.06-11.73%
BIIB Vanguard Health Care Fund 2014-09-30233,6000.10.2-58.26%
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Artavanis-Tsakonas SpyridonSVP, Chief Scientific Officer 2014-12-15Sell1,981$346.54.09view
Sandrock AlfredGrp SVP, Chief Medical Officer 2014-12-04Sell440$345.884.28view
Holtzman Steven HEVP Corporate Development 2014-12-02Sell1,749$335.657.45view
Holtzman Steven HEVP Corporate Development 2014-11-11Sell1,750$3309.29view
SCANGOS GEORGE ACEO 2014-11-03Sell1,128$320.7812.44view
Holtzman Steven HEVP Corporate Development 2014-10-01Sell1,750$330.978.97view
SCANGOS GEORGE ACEO 2014-10-01Sell1,127$330.978.97view
SCANGOS GEORGE ACEO 2014-09-02Sell1,128$345.474.4view
SCANGOS GEORGE ACEO 2014-08-01Sell1,128$332.938.33view
SCANGOS GEORGE ACEO 2014-07-16Sell12,316$312.3715.46view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    Pfizer Spreading Its Wings Into A New Domain Of Life Sciences Dec 09 2014 
    Biogen’s Alzheimer’s Drug Moves to Phase III Dec 03 2014 
    Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
    Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 
    Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 
    A Few Reasons Why AbbVie's Momentum Will Continue Sep 25 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 
    Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
    Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS Feb 09 2014 


    More From Other Websites
    Roche Drugs For Alzheimer's, Breast Cancer Disappoint Dec 19 2014
    Cramer's perfect recipe for a Santa Claus rally Dec 18 2014
    Juiced By Fed, Stocks Rocket Higher; Biogen Up 6% Dec 18 2014
    Stocks Hold Near Session Highs; FedEx Bounces Back Dec 18 2014
    Harvard Scientist Lights Up Neurons to Find Brain Cures Dec 17 2014
    Where is Santa rally? Dec 15 2014
    Biotech Entrepreneur Tony Coles Takes Aim At Parkinson's And Alzheimer's Dec 15 2014
    Alder Biopharmaceuticals Slumps: ALDR Falls 5.5% in Session Dec 15 2014
    Meet 5 Top Biotech Stocks Holding Up In Shaky Market Dec 13 2014
    Teva's (TEVA) 2015 Guidance Hit By Generics Dec 12 2014
    Celladon Corporation (CLDN) Falls: Stock Goes Down 8.6% Dec 12 2014
    PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties Dec 11 2014
    Lilly Upgraded On 2 Potential Blockbuster Drugs Dec 11 2014
    The Biotech Stock With The Most Upside In 2015, According To Morgan Stanley Dec 11 2014
    Biogen Idec (BIIB) Stock: Moving Average Crossover Alert Dec 11 2014
    Ophthotech Corporation (OPHT) Jumps: Stock Gains 5% Dec 11 2014
    Biotech Stock Roundup: Cubist to be Acquired by Merck, Bluebird Shoots Up on ASH Data Dec 10 2014
    Celgene Up on Positive Revlimid Data Presented at ASH Dec 09 2014
    Rexahn Pharmaceuticals, Inc. (RNN) Rises: Stock Up 8.6% Dec 09 2014
    bluebird bio (BLUE) in Focus: Stock Surges 9.4% Dec 09 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK